• Ep 147 Tasmanian Devil Facial Tumor Disease: Sympathy for the Devil

  • Jul 30 2024
  • Duración: 1 h y 27 m
  • Podcast
  • 5.0 out of 5 stars (1 calificación)

Ep 147 Tasmanian Devil Facial Tumor Disease: Sympathy for the Devil

  • Resumen

  • Think of an infectious disease. What comes to mind? A viral infection like influenza? Or a bacterial illness like cholera? Maybe some of you thought of a fungal pathogen or a parasite. But how many of you thought of a cancer? In this episode, we explore the bizarre, stranger than fiction story of devil facial tumor disease (DFTD), a transmissible cancer that has devastated Tasmanian devil populations over the past few decades. And when we say transmissible cancer, we don’t mean a cancer caused by a virus - we mean the cancer itself is transmissible. How is that possible? What does it do to the devils? What are Tasmanian devils like? What role do they play in the ecosystem? What does the future hold for these adorable creatures? Tune in for a lively discussion all about these devils and their disease, featuring Dr. Rodrigo Hamede, Senior Lecturer at the University of Tasmania and DFTD expert. This episode will have you looking up pictures of baby devils, listening to their wide range of sounds, and rethinking the lines between contagious and non-contagious disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos

Lo que los oyentes dicen sobre Ep 147 Tasmanian Devil Facial Tumor Disease: Sympathy for the Devil

Calificaciones medias de los clientes
Total
  • 5 out of 5 stars
  • 5 estrellas
    1
  • 4 estrellas
    0
  • 3 estrellas
    0
  • 2 estrellas
    0
  • 1 estrella
    0
Ejecución
  • 5 out of 5 stars
  • 5 estrellas
    1
  • 4 estrellas
    0
  • 3 estrellas
    0
  • 2 estrellas
    0
  • 1 estrella
    0
Historia
  • 5 out of 5 stars
  • 5 estrellas
    1
  • 4 estrellas
    0
  • 3 estrellas
    0
  • 2 estrellas
    0
  • 1 estrella
    0

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.